Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 22, 2025
Tirzepatide Was Associated with Improved Health-Related Quality of Life in Adults with Obesity or Overweight and Type 2 Diabetes: Results from the Phase 3 SURMOUNT-2 Trial
Theresa Hunter Gibble, Dachuang Cao, Xiaotian Michelle Zhang, et al.
Diabetes, Obesity & Metabolism
|
November 5, 2024
Association between weight reduction achieved with tirzepatide and quality of life in adults with obesity: Results from the SURMOUNT-1 study
Kimberly A Gudzune, Adam Stefanski, Dachuang Cao, et al.
Diabetes Technology & Therapeutics
|
May 27, 2020
Ultra-Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy
Maciej T Malecki, Dachuang Cao, Rong Liu, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
October 7, 2015
Erratum to: Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis
Haoda Fu, Dachuang Cao, Kristina S Boye, et al.
Diabetes, Obesity & Metabolism
|
June 4, 2020
Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26-week PRONTO-T1D study
Leslie Klaff, Dachuang Cao, Mary Anne Dellva, et al.
The New England Journal of Medicine
|
April 1, 2011
Growth hormone plus childhood low-dose estrogen in Turner's syndrome
Judith L Ross, Charmian A Quigley, Dachuang Cao, et al.
Diabetes, Obesity & Metabolism
|
June 25, 2026
Tirzepatide Efficacy and Tolerability According to Early Weight Response: A Post Hoc Analysis of the SURMOUNT-1 and SURMOUNT-2 Trials
Alexander Kokkinos, Tina Thethi, Clare J Lee, et al.
Primary Care Diabetes
|
November 28, 2018
Associated factors that influenced persistence with basal analog insulin therapy among people with type 2 diabetes: An exploratory analysis from a UK real-world sample
Iskandar Idris, Kunal Gulati, Magaly Perez-Nieves, et al.
Postgraduate Medicine
|
March 25, 2018
Insulin non-persistence among people with type 2 diabetes: how to get your patients to stay on insulin therapy
Theresa L Garnero, Nichola J Davis, Magaly Perez-Nieves, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
July 6, 2015
Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis
Haoda Fu, Dachuang Cao, Kristina S Boye, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 22, 2025
Tirzepatide Was Associated with Improved Health-Related Quality of Life in Adults with Obesity or Overweight and Type 2 Diabetes: Results from the Phase 3 SURMOUNT-2 Trial
Theresa Hunter Gibble, Dachuang Cao, Xiaotian Michelle Zhang, et al.
Diabetes, Obesity & Metabolism
|
November 5, 2024
Association between weight reduction achieved with tirzepatide and quality of life in adults with obesity: Results from the SURMOUNT-1 study
Kimberly A Gudzune, Adam Stefanski, Dachuang Cao, et al.
Diabetes Technology & Therapeutics
|
May 27, 2020
Ultra-Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy
Maciej T Malecki, Dachuang Cao, Rong Liu, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
October 7, 2015
Erratum to: Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis
Haoda Fu, Dachuang Cao, Kristina S Boye, et al.
Diabetes, Obesity & Metabolism
|
June 4, 2020
Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26-week PRONTO-T1D study
Leslie Klaff, Dachuang Cao, Mary Anne Dellva, et al.
The New England Journal of Medicine
|
April 1, 2011
Growth hormone plus childhood low-dose estrogen in Turner's syndrome
Judith L Ross, Charmian A Quigley, Dachuang Cao, et al.
Diabetes, Obesity & Metabolism
|
June 25, 2026
Tirzepatide Efficacy and Tolerability According to Early Weight Response: A Post Hoc Analysis of the SURMOUNT-1 and SURMOUNT-2 Trials
Alexander Kokkinos, Tina Thethi, Clare J Lee, et al.
Primary Care Diabetes
|
November 28, 2018
Associated factors that influenced persistence with basal analog insulin therapy among people with type 2 diabetes: An exploratory analysis from a UK real-world sample
Iskandar Idris, Kunal Gulati, Magaly Perez-Nieves, et al.
Postgraduate Medicine
|
March 25, 2018
Insulin non-persistence among people with type 2 diabetes: how to get your patients to stay on insulin therapy
Theresa L Garnero, Nichola J Davis, Magaly Perez-Nieves, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
July 6, 2015
Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis
Haoda Fu, Dachuang Cao, Kristina S Boye, et al.
Page
of 5